glp 1 agonist liraglutide Study shows results in increased insulin sensitivity independent of weight loss Structure of [ 3 H]liraglutide

doi: 10.1039/d1fo01935j

Activation of GLP-1R also triggers the PI3K/Akt signaling pathway via the subunits of G proteins, thereby promoting -cell viability and replicative capacity ( 2.2 Inflammation and immune modulation Recent preclinical studies have demonstrated its bidirectional immunomodulatory effects, including improvement of organ dysfunction, regulation of immune responses, and mitigation of sepsis-associated cytokine storms, mediated through anti-inflammatory and anti-apoptotic pathways

Secondly, consider the efficacy of each medication

According to the post-hoc analysis of SURPASS-3 (NCT03882970), 52 weeks of tirzepatide treatment resulted in a 4.4% reduction in MFI in individuals with T2DM [85]

D.PachecoB

3) exenatide OR lixisenatide OR liraglutide OR semaglutide OR albiglutide OR dulaglutide OR efpeglenatide